Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Endometrioid Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Women's hospital school of medicine zhejiang university, Hangzhou, Zhejiang, China
Contact: Study coordinator (Yang Li, PhD) · li_yang@zju.edu.cn · 86-15858223899

Study leads

Hui Wang, PHD
Principal Investigator
Women's Hospital School Of Medicine Zhejiang University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Endometrial Cancer

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States · San Francisco, United States

Study of EV for Recurrent Endometrial Carcinoma

Endometrial Cancer

Abroad (travel likely)RecruitingPHASE2

Milwaukee, United States

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Endometrial Cancer · Endometrioid Tumor · Cancer

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Miami Beach, United States

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Endometrial Cancer · Endometrioid Adenocarcinoma · Endometrial Cancer Stage I

Abroad (travel likely)Recruiting

Hartford, United States · Miami, United States